157 related articles for article (PubMed ID: 31331787)
1. Predictive Genes for the Prognosis of Central Serous Chorioretinopathy.
Hosoda Y; Yamashiro K; Miyake M; Ooto S; Oishi A; Miyata M; Uji A; Khor CC; Wong TY; Tsujikawa A
Ophthalmol Retina; 2019 Nov; 3(11):985-992. PubMed ID: 31331787
[TBL] [Abstract][Full Text] [Related]
2. GENETIC FACTORS ASSOCIATED WITH CHOROIDAL VASCULAR HYPERPERMEABILITY AND SUBFOVEAL CHOROIDAL THICKNESS IN POLYPOIDAL CHOROIDAL VASCULOPATHY.
Yoneyama S; Sakurada Y; Kikushima W; Sugiyama A; Tanabe N; Mabuchi F; Kubota T; Iijima H
Retina; 2016 Aug; 36(8):1535-41. PubMed ID: 26745149
[TBL] [Abstract][Full Text] [Related]
3. Associations of complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genotypes with subtypes of polypoidal choroidal vasculopathy.
Tanaka K; Nakayama T; Mori R; Sato N; Kawamura A; Mizutani Y; Yuzawa M
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7441-4. PubMed ID: 21896867
[TBL] [Abstract][Full Text] [Related]
4.
Hosoda Y; Yoshikawa M; Miyake M; Tabara Y; Ahn J; Woo SJ; Honda S; Sakurada Y; Shiragami C; Nakanishi H; Oishi A; Ooto S; Miki A; ; Iida T; Iijima H; Nakamura M; Khor CC; Wong TY; Song K; Park KH; Yamada R; Matsuda F; Tsujikawa A; Yamashiro K
Proc Natl Acad Sci U S A; 2018 Jun; 115(24):6261-6266. PubMed ID: 29844195
[TBL] [Abstract][Full Text] [Related]
5. Genetic factors associated with treatment response to reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy.
Hayashida M; Miki A; Nakai S; Matsumiya W; Imai H; Kusuhara S; Honda S; Nakamura M
Mol Vis; 2020; 26():505-509. PubMed ID: 32774081
[TBL] [Abstract][Full Text] [Related]
6. Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration.
de Jong EK; Breukink MB; Schellevis RL; Bakker B; Mohr JK; Fauser S; Keunen JE; Hoyng CB; den Hollander AI; Boon CJ
Ophthalmology; 2015 Mar; 122(3):562-70. PubMed ID: 25439433
[TBL] [Abstract][Full Text] [Related]
7. Associations of Single-Nucleotide Polymorphisms in Slovenian Patients with Acute Central Serous Chorioretinopathy.
Kiraly P; Zupan A; Matjašič A; Mekjavić PJ
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052395
[TBL] [Abstract][Full Text] [Related]
8. GENETIC RISK FACTORS IN ACUTE CENTRAL SEROUS CHORIORETINOPATHY.
Mohabati D; Schellevis RL; van Dijk EHC; Altay L; Fauser S; Hoyng CB; De Jong EK; Boon CJF; Yzer S
Retina; 2019 Dec; 39(12):2303-2310. PubMed ID: 30300269
[TBL] [Abstract][Full Text] [Related]
9. One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.
Fujita K; Imamura Y; Shinoda K; Matsumoto CS; Mizutani Y; Hashizume K; Mizota A; Yuzawa M
Ophthalmology; 2015 Mar; 122(3):555-61. PubMed ID: 25444637
[TBL] [Abstract][Full Text] [Related]
10. Association of Irregular Pigment Epithelial Detachment in Central Serous Chorioretinopathy with Genetic Variants Implicated in Age-related Macular Degeneration.
Cho SC; Ryoo NK; Ahn J; Woo SJ; Park KH
Sci Rep; 2020 Jan; 10(1):1203. PubMed ID: 31988359
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Genetic Characteristics of Pachydrusen in Eyes with Central Serous Chorioretinopathy and General Japanese Individuals.
Takahashi A; Hosoda Y; Miyake M; Miyata M; Oishi A; Tamura H; Ooto S; Yamashiro K; Tabara Y; Matsuda F; Tsujikawa A
Ophthalmol Retina; 2021 Sep; 5(9):910-917. PubMed ID: 33309963
[TBL] [Abstract][Full Text] [Related]
12. Clinical Features of Central Serous Chorioretinopathy With Type 1 Choroidal Neovascularization.
Shiragami C; Takasago Y; Osaka R; Kobayashi M; Ono A; Yamashita A; Hirooka K
Am J Ophthalmol; 2018 Sep; 193():80-86. PubMed ID: 29940168
[TBL] [Abstract][Full Text] [Related]
13. Age-Related Maculopathy Susceptibility 2 and Complement Factor H Polymorphism and Intraocular Complement Activation in Neovascular Age-Related Macular Degeneration.
Kato Y; Oguchi Y; Omori T; Kasai A; Ogasawara M; Sugano Y; Itagaki K; Ojima A; Ishida Y; Machida T; Sekine H; Sekiryu T
Ophthalmol Sci; 2022 Jun; 2(2):100167. PubMed ID: 36249678
[TBL] [Abstract][Full Text] [Related]
14. Association between central serous chorioretinopathy susceptibility genes and choroidal parameters.
Morino K; Miyake M; Kamei T; Kawaguchi T; Mori Y; Hosoda Y; Uji A; Yamashiro K; Matsuda F; Tsujikawa A
Jpn J Ophthalmol; 2022 Nov; 66(6):504-510. PubMed ID: 36181643
[TBL] [Abstract][Full Text] [Related]
15. Flat irregular retinal pigment epithelium detachments in chronic central serous chorioretinopathy and choroidal neovascularization.
Hage R; Mrejen S; Krivosic V; Quentel G; Tadayoni R; Gaudric A
Am J Ophthalmol; 2015 May; 159(5):890-903.e3. PubMed ID: 25709063
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide Survival Analysis for Macular Neovascularization Development in Central Serous Chorioretinopathy Revealed Shared Genetic Susceptibility with Polypoidal Choroidal Vasculopathy.
Mori Y; Miyake M; Hosoda Y; Miki A; Takahashi A; Muraoka Y; Miyata M; Sato T; Tamura H; Ooto S; Yamada R; Yamashiro K; Nakamura M; Tajima A; Nagasaki M; Honda S; Tsujikawa A
Ophthalmology; 2022 Sep; 129(9):1034-1042. PubMed ID: 35490733
[TBL] [Abstract][Full Text] [Related]
17. Findings of OCT-angiography compared to fluorescein and indocyanine green angiography in central serous chorioretinopathy.
Min JY; Lv Y; Yu S; Gong YY
Lasers Surg Med; 2018 Dec; 50(10):987-993. PubMed ID: 29896889
[TBL] [Abstract][Full Text] [Related]
18. Three-year follow-up of choroidal neovascularisation in eyes of chronic central serous chorioretinopathy.
Chen YC; Chen SN
Br J Ophthalmol; 2020 Nov; 104(11):1561-1566. PubMed ID: 32051140
[TBL] [Abstract][Full Text] [Related]
19. Choroidal neovascularization in eyes with choroidal vascular hyperpermeability.
Miyake M; Tsujikawa A; Yamashiro K; Ooto S; Oishi A; Tamura H; Nakata I; Matsuda F; Yoshimura N
Invest Ophthalmol Vis Sci; 2014 Apr; 55(5):3223-30. PubMed ID: 24781946
[TBL] [Abstract][Full Text] [Related]
20. Central serous chorioretinopathy: risk factors for serous retinal detachment in fellow eyes.
Shinojima A; Mehanna C; Lavia CA; Gaudric A; Tadayoni R; Bousquet E
Br J Ophthalmol; 2020 Jun; 104(6):852-856. PubMed ID: 31473627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
